STAAR Surgical Company (STAA) Q2 2026 Earnings Call August 12, 2026 5:30 PM EDT
Company Participants
Connie Johnson – Director of Investor Relations
Warren Foust – CEO, President & Director
Deborah Andrews – Executive VP & CFO
Conference Call Participants
John Young – Canaccord Genuity Corp., Research Division
Thomas Stephan – Stifel, Nicolaus & Company, Incorporated, Research Division
Anthony Petrone – Mizuho Securities USA LLC, Research Division
Gursimran Kaur – Wells Fargo Securities, LLC, Research Division
Ryan Zimmerman – BTIG, LLC, Research Division
David Saxon – Needham & Company, LLC, Research Division
Harrison Parsons – Stephens Inc., Research Division
Adam Maeder – Piper Sandler & Co., Research Division
Presentation
Operator
Welcome to the STAAR Surgical second quarter 2026 results conference call and webcast. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Connie Johnson, Director of Investor Relations.
Connie Johnson
Director of Investor Relations
Thank you, operator. Good afternoon and thank you for joining us. On the call today are Warren Foust, President and Chief Executive Officer of STAAR Surgical, and Deborah Andrews, Executive Vice President and Chief Financial Officer of STAAR Surgical. Earlier today, we reported our second quarter 2026 results via a press release in Form 8-K. We posted our results, release, and shareholder letter to our investor website at investors.staar.com. Today’s call is scheduled for 1 hour and will include Q&A for publishing analysts. Webcast participants can also send questions for today’s Q&A session to ir@staar.com.
Before we get started, I want to remind you that during today’s discussion, we will be making forward-looking statements. Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements. I encourage you to read the disclosures in today’s release, as well as on our filings with the SEC. Except









You must be logged in to post a comment Login